middl
east
respiratori
syndrom
coronaviru
merscov
novel
human
coronaviru
first
isol
arabian
peninsula
zaki
et
al
merscov
positivesens
envelop
singlestrand
rna
viru
genu
betacoronaviru
within
subfamili
coronavirina
de
groot
et
al
merscov
infect
often
caus
fever
cough
sever
pneumonia
occasion
accompani
renal
diseas
banik
et
al
laboratoryconfirm
case
high
fatal
rate
mortal
report
world
health
organ
current
specif
antivir
drug
vaccin
approv
clinic
use
merscov
rapid
diagnost
test
urgent
requir
manag
control
viru
inde
rapid
specif
diagnosi
essenti
prevent
spread
kind
infecti
diseas
present
laboratori
test
merscov
perform
quantit
revers
transcriptionpcr
assay
qrtpcr
rtloopmedi
isotherm
amplif
rtlamp
corman
et
al
b
shirato
et
al
test
detect
nucleic
acid
deriv
merscov
clinic
respiratori
serum
stool
specimen
nucleic
acidbas
test
requir
molecular
techniqu
special
equip
thu
suitabl
pointofcar
test
poct
bedsid
diagnosi
therefor
necessari
develop
altern
method
adapt
rapid
reliabl
clinic
detect
merscov
antigen
includ
enzymelink
immunosorb
assay
elisa
immunochromatograph
test
ict
middl
east
respiratori
syndrom
coronaviru
compris
four
structur
protein
spike
envelop
e
membran
nucleocapsid
n
van
boheemen
et
al
protein
major
compon
viral
surfac
bind
dipeptidyl
peptidas
enabl
viru
enter
infect
cell
raj
et
al
therefor
protein
consid
prospect
therapeut
diagnost
target
song
et
al
jiang
et
al
zhang
et
al
li
et
al
howev
neutral
antibodi
mainli
target
antigen
coronavirus
express
sever
mutant
form
protein
order
escap
immun
respons
achiev
viral
persist
tang
et
al
hand
aminoacid
mutat
n
protein
much
less
common
werneri
et
al
n
protein
produc
high
level
within
infect
cell
thu
promis
candid
target
clinic
diagnosi
lau
et
al
et
al
kogaki
et
al
liang
et
al
chen
et
al
n
protein
function
packag
viral
genom
rna
form
helic
nucleocapsid
well
viral
transcript
assembl
mcbride
et
al
three
distinct
conserv
domain
ntermin
domain
ntd
linker
region
lkr
ctermin
domain
ctd
mcbride
et
al
ntd
human
coronaviru
n
protein
contain
highli
conserv
motif
yu
et
al
chang
et
al
prevent
crossreact
human
coronavirus
specif
detect
merscov
necessari
develop
antibodi
target
nonconserv
region
howev
viral
structur
protein
gener
unstabl
insolubl
monomer
oligomer
form
make
difficult
prepar
antigen
immun
moreov
refold
solubil
viral
protein
denatur
agent
often
result
misfold
function
loss
schein
overcom
problem
recent
develop
cellfre
base
viral
protein
product
system
use
wheat
germ
extract
matsunaga
et
al
wheat
eukaryot
system
synthes
properli
fold
biolog
activ
viral
protein
equival
express
mammalian
cell
endo
sawasaki
goshima
et
al
studi
synthes
recombin
merscov
n
protein
mersnp
rais
monoclon
antibodi
mab
could
specif
detect
protein
also
describ
develop
evalu
rapid
test
format
includ
elisa
ict
use
poct
merscov
infect
complementari
dna
encod
nucleocapsid
protein
np
human
coronavirus
merscov
genbank
sarscov
genbank
genbank
genbank
genbank
genbank
synthes
genewiz
south
plainfield
nj
usa
synthet
cdna
digest
xhoi
kpni
insert
gener
express
vector
antigen
product
wheat
germ
cellfre
system
mersnp
open
read
frame
encod
amino
acid
amplifi
pcr
use
forward
primer
revers
primer
amplifi
fragment
clone
ecorv
site
vector
cellfre
scienc
yokohama
japan
delet
mutant
mersnp
epitop
map
gener
use
primestar
mutagenesi
basal
kit
takara
bio
otsu
japan
mutat
introduc
mersnp
use
primestar
mutagenesi
basal
kit
takara
bio
otsu
japan
vitro
transcript
cellfre
protein
synthesi
perform
previous
describ
takai
endo
takai
et
al
senchi
et
al
matsunaga
et
al
cellfre
protein
synthesi
wheat
germ
extract
cellfre
scienc
yokohama
japan
use
bilay
translat
method
previous
describ
matsunaga
et
al
synthes
protein
confirm
immunoblot
hismersnp
protein
use
mous
immun
synthes
use
protemist
xe
robot
protein
synthes
cellfre
scienc
yokohama
japan
cellfre
translat
reaction
mixtur
ml
separ
solubl
insolubl
fraction
centrifug
rpm
min
solubl
fraction
mix
nisepharos
high
perform
bead
ge
healthcar
waukesha
wi
usa
presenc
mm
imidazol
bead
wash
three
time
wash
buffer
mm
trishcl
ph
mm
nacl
contain
mm
imidazol
hismersnp
elut
wash
buffer
contain
mm
imidazol
amicon
ultra
centrifug
filter
millipor
bedford
usa
use
concentr
purifi
hismersnp
approxim
protein
concentr
determin
use
bradford
method
bovin
serum
albumin
bsa
protein
standard
immun
balbc
mice
gener
hybridoma
produc
antimersnp
antibodi
carri
previous
describ
kimura
et
al
matsunaga
et
al
primari
antibodi
hybridoma
cultur
supernat
test
immunoblot
analysi
nontag
recombin
n
protein
anim
experi
perform
ethic
accord
guidelin
anim
experi
yokohama
citi
univers
procedur
approv
committe
experiment
anim
yokohama
citi
univers
hybridoma
cell
grown
cd
hybridoma
medium
agt
medium
thermo
fisher
scientif
rockford
il
usa
primari
antibodi
cultur
supernat
clone
separ
centrifug
rpm
min
elut
acrosep
hyper
df
column
pall
new
york
ny
usa
sampl
concentr
use
amicon
ultra
centrifug
filter
millipor
bedford
usa
concentr
purifi
igg
determin
measur
absorb
immunoglobulin
character
carri
use
isostrip
mous
monoclon
antibodi
isotyp
kit
roch
diagnost
basel
switzerland
dimer
model
mersnp
construct
homolog
model
base
partial
structur
sarsnp
pdb
code
huang
et
al
pdb
code
chen
et
al
use
softwar
webb
sali
protein
structur
regist
pdb
estim
itass
quark
server
use
templat
homolog
model
xu
zhang
yang
et
al
energi
minim
gener
model
carri
use
swiss
pdb
guex
peitsch
surfac
local
epitop
determin
use
ucsf
chimera
softwar
pettersen
et
al
immunoprecipit
perform
previous
describ
miyakawa
et
al
briefli
cell
grown
dish
h
transfect
hamersnp
cell
lysat
immunoprecipit
ezview
red
antiha
affin
gel
antimersnp
antibodi
mix
protein
gsepharos
ge
healthcar
littl
chalfont
uk
bound
protein
analyz
immunoblot
mab
dilut
mm
carbon
buffer
ph
concentr
ad
elisa
plate
agc
techno
glass
shizuoka
japan
immobil
antibodi
plate
incub
overnight
well
block
pb
contain
wv
skim
milk
h
room
temperatur
rt
three
wash
pb
contain
vv
pbst
antigen
protein
ngml
dilut
pbst
blank
pbst
alon
ad
incub
min
rt
three
wash
pbst
mab
conjug
horseradish
peroxidas
hrp
ad
well
incub
min
rt
antibodi
label
perform
use
peroxidas
label
kit
dojindo
laboratori
kumamoto
japan
three
wash
pbst
abt
substrat
solut
kirkegaard
perri
laboratori
washington
dc
usa
ad
incub
min
rt
absorb
nm
measur
plate
reader
signaltonois
ratio
sn
calcul
test
line
antimersnp
antibodi
dilut
mm
phosphat
buffer
ph
concentr
mgml
immobil
nitrocellulos
membran
millipor
bedford
usa
prepar
control
line
antimous
igg
antibodi
dilut
mgml
immobil
onto
anoth
area
membran
membran
dri
block
rt
wash
deioniz
water
lyophil
produc
conjug
pad
antimersnp
mab
dilut
mm
phosphat
buffer
ph
concentr
mgml
label
colloid
gold
tanaka
kikinzoku
kogyo
tokyo
japan
colloid
goldconjug
mab
block
casein
kanto
chemic
tokyo
japan
wash
three
time
phosphat
buffer
ph
label
mab
dilut
impregn
glass
fiber
millipor
bedford
usa
glass
fiber
lyophil
immunochromatograph
strip
gener
assembl
glass
fiber
sampl
pad
conjug
pad
nitrocellulos
membran
liquid
absorb
pad
compar
combin
antibodi
antigen
protein
dilut
ml
mm
phosphat
buffer
contain
mm
nacl
appli
strip
color
intens
red
line
test
control
posit
background
membran
visual
observ
evalu
min
reaction
homolog
np
among
human
coronavirus
merscov
genbank
sarscov
genbank
genbank
genbank
genbank
genbank
analyz
multipl
sequenc
align
use
muscl
softwar
edgar
examin
aminoacid
variabl
among
np
merscov
strain
mersnp
sequenc
genbank
align
use
muscl
softwar
shannon
entropi
score
calcul
posit
protein
align
previous
describ
yang
phylogenet
tree
gener
via
maximumlikelihood
method
bootstrap
replic
use
remov
ident
sequenc
tamura
et
al
dataset
analyz
use
jtt
aminoacid
substitut
model
prototyp
strain
merscov
provid
dr
ron
fouchier
bart
l
haagman
erasmu
medic
center
merscov
propag
vero
cell
express
describ
previous
shirato
et
al
viral
sampl
concentr
centrifug
cultur
supernat
merscov
infect
cell
merscov
inactiv
addit
nonidet
final
concentr
vv
prior
immunoassay
viral
rna
extract
sampl
use
qiaamp
viral
rna
mini
kit
qiagen
valencia
ca
usa
quantit
viral
copi
number
carri
reversetranscript
droplet
digit
pcr
rtddpcr
use
onestep
rtddpcr
advanc
kit
probe
biorad
hercul
ca
usa
reaction
set
contain
rna
equival
ng
mixtur
forwardrevers
primer
probe
mm
dtt
revers
transcriptas
rnasefre
water
supermix
primer
probe
set
use
previous
report
qrtpcr
assay
corman
et
al
final
concentr
primer
probe
nm
respect
droplet
form
droplet
gener
biorad
hercul
ca
usa
thermal
cycl
condit
follow
min
rt
reaction
min
cycl
min
final
min
denatur
step
thermal
cycl
plate
transfer
droplet
reader
biorad
hercul
ca
usa
posit
droplet
contain
amplif
product
discrimin
neg
droplet
appli
fluoresc
amplitud
threshold
quantasoft
softwar
biorad
hercul
ca
usa
cellfre
synthes
protein
cell
cultur
supernat
contain
inactiv
merscov
mix
equal
volum
sd
sampl
buffer
mm
trishcl
ph
sd
glycerol
bromophenol
blue
heat
min
separ
sdspage
use
hiqra
gel
n
kanto
chemic
tokyo
japan
protein
electrotransf
onto
immobilonp
pvdf
transfer
membran
millipor
bedford
usa
describ
previous
nishi
et
al
membran
block
trisbuff
salin
tb
contain
wv
skim
milk
min
incub
h
antimersnp
mab
antihi
polyclon
antibodi
genetex
irvin
ca
usa
tb
contain
vv
tween
tbst
dilut
wv
skim
milk
three
wash
tbst
membran
incub
min
pb
contain
hrpconjug
goatanti
mous
rabbit
igg
antibodi
dilut
ge
healthcar
addit
three
wash
tbst
protein
detect
supersign
west
dura
extend
durat
substrat
thermo
fisher
scientif
rockford
il
usa
immobilon
millipor
bedford
usa
lumiimag
roch
diagnost
basel
switzerland
sensit
analysi
antigencaptur
elisa
carri
describ
modif
briefli
mab
immobil
onto
plate
concentr
plate
block
inactiv
merscov
ml
recombin
antigen
protein
ml
serial
twofold
dilut
pbst
subject
analysi
reaction
hrpconjug
mab
chromogen
reaction
conduct
ad
tmb
substrat
solut
kirkegaard
perri
laboratori
washington
dc
usa
per
well
follow
incub
min
reaction
halt
addit
absorb
nm
measur
plate
reader
immunochromatograph
detect
merscov
carri
describ
modif
prepar
conjug
pad
conjug
mab
colloid
gold
perform
concentr
mgml
block
wash
conjug
pad
impregn
label
antibodi
solut
sensit
ict
evalu
ad
serial
twofold
dilut
inactiv
merscov
ml
recombin
antigen
protein
ml
previou
studi
describ
antigen
crossreact
among
ntd
n
protein
human
coronavirus
includ
sarscov
yu
et
al
minim
crossreact
gener
mab
produc
ntermin
delet
mersnp
amino
acid
antigen
antibodi
product
complementari
dna
encod
mersnp
subclon
peuhi
vector
design
express
histag
protein
wheat
germ
cellfre
system
predict
histag
mersnp
express
figur
protein
purifi
solubl
fraction
extract
use
nisepharos
bead
follow
elut
imidazol
purifi
protein
use
immun
balbc
mice
week
splenocyt
isol
hybridoma
gener
figur
ultim
stabl
hybridoma
obtain
design
among
clone
seven
select
investig
base
reactiv
mersnp
immunoblot
analysi
figur
next
perform
epitop
map
determin
antibodi
bind
site
use
cell
freesynthes
delet
mutant
mersnp
carri
immunoblot
analys
gener
antibodi
first
screen
use
six
delet
mutant
figur
b
result
reveal
two
mab
recogn
middl
region
correspond
lkr
wherea
remain
five
mab
bound
ctermin
end
protein
figur
b
precis
epitop
map
perform
use
five
addit
delet
mutant
figur
b
result
summar
figur
next
investig
whether
antigen
epitop
locat
surfac
mersnp
end
use
previous
report
solut
structur
sarsnp
pdb
id
homolog
model
mersnp
huang
et
al
chen
et
al
molecular
model
mersnp
use
ucsf
chimera
softwar
reveal
mab
bind
region
locat
surfac
n
protein
figur
next
antibodi
suitabl
immunoprecipit
like
conformationsensit
examin
whether
select
antibodi
could
use
immunoprecipit
analysi
mancia
et
al
takeda
et
al
cell
lysat
cell
express
hatag
mersnp
subject
immunoprecipit
analysi
select
antibodi
figur
result
reveal
gener
mab
could
use
immunoprecipit
analysi
next
determin
optim
pair
mab
antigencaptur
elisa
evalu
possibl
combin
immobil
label
mab
figur
combin
exhibit
higher
sn
ratio
pair
figur
base
data
construct
immunochromatograph
strip
use
five
pair
mab
figur
search
combin
yield
highest
color
intens
posit
control
appropri
posit
lowest
overal
background
rest
membran
found
immobil
mab
colloid
gold
conjug
optim
combin
ict
figur
c
thu
select
mab
investig
next
investig
specif
newli
develop
mab
multipl
align
np
deriv
variou
human
coronavirus
reveal
aminoacid
sequenc
target
select
antibodi
specif
merscov
figur
consist
data
immunoblot
analysi
reveal
mab
recogn
np
coronavirus
figur
estim
reactiv
mab
differ
strain
merscov
compar
aminoacid
sequenc
epitop
isol
strain
shannon
entropi
phylogenet
analysi
reveal
aminoacid
sequenc
mersnp
highli
conserv
figur
b
notabl
obviou
aminoacid
mutat
observ
bind
region
figur
c
howev
ctermin
amino
acid
sequenc
target
rather
variabl
contain
specif
mutat
two
strain
figur
c
therefor
perform
sitedirect
mutagenesi
introduc
mutat
mersnp
examin
effect
reactiv
antibodi
immunoblot
analysi
result
show
mab
could
still
detect
mutant
figur
next
perform
immunoblot
analysi
virion
releas
cellcultur
supernat
merscov
infect
cell
mab
detect
kda
protein
band
consist
molecular
mass
mersnp
figur
band
detect
mab
demonstr
specif
mersnp
thu
newli
develop
antibodi
could
detect
np
antigen
deriv
merscov
virion
well
recombin
np
use
optim
antibodi
pair
identifi
determin
detect
threshold
antigen
recognit
antigencaptur
elisa
result
reveal
system
highli
sensit
recombin
antigen
capabl
detect
protein
concentr
ml
figur
parallel
investig
detect
limit
elisa
merscov
virion
permeabil
addit
detect
limit
system
ml
figur
final
evalu
sensit
ict
merscov
purpos
serial
dilut
purifi
np
subject
ict
result
reveal
ict
highli
sensit
detect
limit
ml
next
examin
detect
limit
virion
prepar
phosphat
buffer
contain
ict
could
detect
virion
concentr
ml
figur
report
develop
prospect
evalu
elisa
ict
quantit
qualit
detect
merscovnp
antigen
newli
develop
assay
provid
rapid
detect
broad
rang
np
antigen
deriv
variou
isol
merscov
np
princip
structur
protein
abundantli
express
merscov
antigen
target
np
clinic
diagnosi
reason
practic
chen
et
al
qualiti
mab
determin
mostli
antigen
design
adjuv
select
antigen
qualiti
leenaar
hendriksen
still
particular
prepar
highqual
antigen
essenti
creation
specif
mab
sever
method
prepar
immun
viru
antigen
includ
synthet
peptid
viruslik
particl
vlp
purifi
recombin
protein
synthet
peptid
contain
predict
immunogen
epitop
wide
use
way
creat
immunogen
deriv
viru
antigen
howev
synthet
peptid
commonli
linear
therefor
often
repres
nativ
featur
antigen
origin
actual
spatial
structur
viral
compon
hand
cellbas
protein
express
system
escherichia
coli
baculovirusinsect
cell
system
also
wide
use
popular
approach
although
number
cellular
protein
success
gener
use
cellbas
approach
feasibl
use
strategi
gener
viral
protein
mani
viral
antigen
includ
human
coronaviru
n
protein
gener
insolubl
aggreg
inclus
bodi
fraction
da
suresh
moreov
viral
protein
often
cytotox
express
protein
particularli
high
level
result
cell
death
cheng
et
al
contrast
cellfre
protein
product
system
permit
synthesi
toxic
protein
otherwis
produc
live
cell
wheat
germ
extract
commonli
use
cellfre
approach
util
eukaryot
translat
system
synthes
properli
fold
biolog
activ
protein
similar
express
mammalian
cell
endo
sawasaki
goshima
et
al
advantag
highlight
suitabl
avail
wheat
germ
cellfre
system
gener
antigen
protein
use
immun
anim
gener
mab
matsunaga
et
al
result
studi
clearli
demonstr
advantag
use
wheat
germ
cellfre
system
creat
mab
merscovnp
gener
mab
divid
two
group
conformationsensit
insensit
antibodi
suitabl
immunoprecipit
immunoblot
conformationinsensit
immunoblottingori
mab
detect
denatur
linear
antigen
peptid
immobil
membran
wherea
conformationsensit
immunoprecipitationori
mab
typic
recogn
nativ
tertiari
structur
antigen
protein
mancia
et
al
takeda
et
al
studi
use
wheat
germ
system
synthes
mersnp
antigen
solubl
protein
consequ
abl
produc
antibodi
specif
target
antigen
epitop
locat
surfac
mersnp
accordingli
newli
develop
antibodi
suitabl
immunoprecipit
indic
sensit
protein
conform
antibodi
bind
protein
surfac
epitop
suitabl
antigen
detect
assay
elisa
ict
newli
creat
antibodi
use
variou
immunolog
assay
merscov
mani
type
human
coronavirus
relat
respiratori
diseas
includ
coronavirus
respons
common
cold
upper
respiratori
diseas
well
sarscov
caus
lifethreaten
pneumonia
therefor
import
creat
mab
high
specif
merscov
order
rule
coronaviru
infect
previou
report
indic
ntd
np
mani
human
coronavirus
share
common
sequenc
yu
et
al
chang
et
al
therefor
use
recombin
merscovnp
devoid
conserv
region
immunogen
produc
mab
consequ
newli
develop
mab
recogn
speciesspecif
aminoacid
sequenc
merscov
consist
mab
crossreact
np
deriv
human
coronavirus
viral
speci
determin
structur
character
capsidnucleocapsid
gelderblom
therefor
suspect
highli
speciesspecif
mab
obtain
due
appropri
design
nativ
properti
antigen
develop
intern
trade
worldwid
travel
bring
signific
risk
spread
emerg
infecti
diseas
includ
merscov
needless
say
obviou
boundari
virusfre
countri
face
endem
thu
establish
rapid
reliabl
laboratori
diagnost
test
pathogen
urgent
matter
countri
wide
use
current
diagnost
merscov
involv
detect
viru
nucleic
acid
qrtpcr
laboratori
corman
et
al
b
although
qrtpcr
sensit
power
tool
obtain
evid
viru
infect
requir
special
lab
equip
expertis
molecular
technolog
moreov
due
time
requir
enzymat
reaction
rather
timeconsum
disadvantag
prevent
qrtpcr
use
poct
therefor
caseori
comprehens
test
conduct
use
multipl
diagnost
assay
enzymelink
immunosorb
assay
ict
two
major
clinic
test
use
detect
viral
antigen
method
employ
pair
mab
use
captur
detect
antibodi
optim
combin
captur
detect
antibodi
thoroughli
investig
test
kit
assembl
studi
util
nativ
fold
antigen
protein
evalu
test
allow
us
identifi
optim
pair
antibodi
detect
merscovnp
antibodi
set
suitabl
detect
merscovnp
either
elisa
ict
earli
stage
ill
high
titer
infecti
virion
viru
antigen
present
lower
respiratori
tract
lrt
sputum
patient
viral
load
lrt
expector
sputum
patient
acut
infect
copiesml
drosten
et
al
kapoor
et
al
corman
et
al
make
feasibl
detect
viral
antigen
merscov
clinic
diagnosi
earli
stage
infect
current
version
assay
detect
elisa
ng
ict
recombin
n
protein
elisa
viral
copi
ict
ensur
feasibl
practic
clinic
test
group
also
develop
antigencaptur
elisa
ict
detect
mersnp
antigen
chen
et
al
song
et
al
song
et
al
use
synthet
peptid
immunogen
rais
npspecif
mab
group
use
recombin
n
protein
antigen
perform
precis
epitop
map
chen
et
al
hand
develop
structuresensit
mab
mersnp
thoroughli
investig
target
epitop
bioinformat
analysi
base
phylogenet
approach
reveal
newli
develop
mab
detect
np
antigen
deriv
exist
isol
merscov
summari
develop
novel
antigendetect
assay
use
newli
creat
mab
rapid
reliabl
assess
np
antigen
merscov
evalu
use
actual
patient
sampl
warrant
usabl
benefit
assay
clinic
diagnosi
merscov
infect
yy
design
perform
research
analyz
data
wrote
manuscript
sm
sf
perform
research
contribut
viru
prepar
analyz
data
sm
perform
research
analyz
data
ym
perform
bioinformat
analysi
hk
hk
mt
tc
edit
manuscript
ar
direct
research
analyz
data
wrote
manuscript
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
